Eli Lilly and Company's Fiscal Year is From January To December - All Figures are in USD, Billions.
The item "Other-Non-Cash-Items" stands at -0.7273 Billion United States Dollars for the trailing twelve months (TTM) period ending 09/30/2025, the lowest value since 03/31/2020.
Eli Lilly and Company's third quarter result of -3.50 Billion USD for the item "Other Non Cash Items" represents a decrease of -3,803.60 percent compared to it's second quarter result.
Also, Eli Lilly and Company's third quarter result of -3.50 Billion USD for the item "Other Non Cash Items" represents a decrease of -235.45 percent compared to it's third quarter result of last year.
Looking again at the trailing twelve months series (TTM), Eli Lilly and Company's third quarter result of -0.7273 Billion USD for the item "Other Non Cash Items" represents a decrease of -113.59 percent compared to it's second quarter result.
Regarding the One-Year-Change of the series, the current value constitutes an decrease of -4.65 Billion United States Dollars compared to the value the year prior.
The 1 year change is -4.65 Billion United States Dollars.
The 3 year change is -2.77 Billion United States Dollars.
The 5 year change is -0.2075 Billion United States Dollars.
The 10 year change is -1.41 Billion United States Dollars.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Johnson & Johnson - Other Non Cash Items | 486,508,953,600.00 |
![]() | AbbVie Inc - Other Non Cash Items | 399,570,305,024.00 |
![]() | Roche Holding AG - Other Non Cash Items | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Other Non Cash Items | 280,205,508,085.11 |
![]() | Novartis AG - Other Non Cash Items | 255,096,620,580.91 |